Dermatology
News
At 52 weeks, complete hair regrowth rates still climbing on deuruxolitinib
Complete responses continued to increase in open-label extensions of phase 3 alopecia areata studies.
News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Opinion
Diagnosing patients with sarcoidosis
Sarcoidosis should always be part of the differential when you see lymphopenia.
News
Lower-extremity lymphedema associated with more skin cancer risk
This is the first large-scale study evaluating the association between LE lymphedema and LE skin cancer.
News
AAD updates guidelines for managing AD with phototherapy and systemic therapies
The work group recommended the inclusion of active comparator arms in randomized, controlled trials as new systemic therapies continue to be...
News
Prurigo nodularis diagnosis delay in skin of color gains added significance
Given the expanding array of therapies, the message of considering prurigo nodularis in Black patients in order to accelerate the time to...
News
The challenges of palmoplantar pustulosis and other acral psoriatic disease
Dermatologists are using a variety of treatments for palmoplantar pustulosis, with no clear first-line choices.
News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
News
Topical ivermectin study sheds light on dysbiosis in rosacea
Research over the past decade has also started to look at the potential role of the skin microbiome in the disease process, but answers have...
News
Dupilumab-associated lymphoid reactions require caution
In cases involving unexpected responses or atypical presentations, clinicians must have a low threshold for stopping dupilumab.